All Stories

  1. Microsampling for antidepressant drug analysis: Current state and perspectives
  2. Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent
  3. Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation
  4. In situ-generated volumetric dried plasma spots for the analysis of edaravone and metabolites in animal models
  5. Exposure of dams to Elexacaftor/ Tezacaftor/Ivacaftor during pregnancy and breastfeeding induces reversible alterations in newborn wild type CD-1 mice
  6. Volumetric absorptive microsampling for in vitro metabolism of the recent synthetic cannabinoid receptor agonist 5F-PB-22
  7. Review: the role of automation in improving the performance and throughput of microsample bioanalysis
  8. Quantitative urine spot microsamples for the chiral analysis of clenbuterol by capillary electrokinetic chromatography
  9. New trends in bioanalysis sampling and pretreatment: How modern microsampling is revolutionising the field
  10. Innovative Solid-Phase Extraction Strategies for Improving the Advanced Chromatographic Determination of Drugs in Challenging Biological Samples
  11. Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine
  12. Evaluation of the Antioxidant Capacity of Fruit Juices by Two Original Analytical Methods
  13. Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers
  14. Green analytical chemistry (GAC) applications in sample preparation for the analysis of anthocyanins in products and by-products from plant sources
  15. Ion-Channel Antiepileptic Drugs: An Analytical Perspective on the Therapeutic Drug Monitoring (TDM) of Ezogabine, Lacosamide, and Zonisamide
  16. Enhanced urinary stability of peptide hormones and growth factors by dried urine microsampling
  17. Discriminating different Cannabis sativa L. chemotypes using attenuated total reflectance - infrared (ATR-FTIR) spectroscopy: A proof of concept
  18. Free and Conjugated Phenolic Profiles and Antioxidant Activity in Quinoa Seeds and Their Relationship with Genotype and Environment
  19. Clinopodium tomentosum (Kunth) Govaerts Leaf Extract Influences in vitro Cell Proliferation and Angiogenesis on Primary Cultures of Porcine Aortic Endothelial Cells
  20. QUANTITATIVE MICROSAMPLING FOR BIOANALYTICAL APPLICATIONS RELATED TO THE SARS-CoV-2 PANDEMIC: USEFULNESS, BENEFITS AND PITFALLS
  21. Fruit Quality Characterization of New Sweet Cherry Cultivars as a Good Source of Bioactive Phenolic Compounds with Antioxidant and Neuroprotective Potential
  22. Analytica—A Journal of Analytical Chemistry and Chemical Analysis
  23. Dried Urine Microsampling Coupled to Liquid Chromatography—Tandem Mass Spectrometry (LC–MS/MS) for the Analysis of Unconjugated Anabolic Androgenic Steroids
  24. Microsampling and LC–MS/MS for antidoping testing of glucocorticoids in urine
  25. Metabolic Syndrome in Schizophrenia: Focus on the Role of Antipsychotic Medications and Indications for Therapeutic Drug Monitoring (TDM) Methods
  26. New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others
  27. Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption
  28. Assessment of capillary volumetric blood microsampling for the analysis of central nervous system drugs and metabolites
  29. Changes in carotenoids, phenolic acids and antioxidant capacity in bread wheat doughs fermented with different lactic acid bacteria strains
  30. Analysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisation
  31. An Original HPLC Method with Coulometric Detection to Monitor Hydroxyl Radical Generation via Fenton Chemistry
  32. In Vitro Anti-Inflammatory Effect of Salvia sagittata Ethanolic Extract on Primary Cultures of Porcine Aortic Endothelial Cells
  33. Perspectives and strategies for anti-doping analysis
  34. Tutorial: Volumetric absorptive microsampling (VAMS)
  35. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches
  36. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs
  37. Enantioseparation and determination of asenapine in biological fluid micromatrices by HPLC with diode array detection
  38. Integrated Evaluation of the Potential Health Benefits of Einkorn-Based Breads
  39. Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
  40. Analytical profiling of selected antioxidants and total antioxidant capacity of goji ( Lycium spp.) berries
  41. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease
  42. TDM of novel antipsychotics
  43. Discontinued anxiolytic drugs (2009 – 2014)
  44. Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder
  45. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients
  46. A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma
  47. Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety
  48. Recent trends in the analysis of amino acids in fruits and derived foodstuffs
  49. Monitoring of chronic Cannabis abuse: An LC–MS/MS method for hair analysis
  50. Quantitative Evaluation of Auraptene and Umbelliferone, Chemopreventive Coumarins in Citrus Fruits, by HPLC-UV-FL-MS
  51. Dried blood spots: Liquid chromatography–mass spectrometry analysis of Δ9-tetrahydrocannabinol and its main metabolites
  52. Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
  53. Content of melatonin and other antioxidants in grape-related foodstuffs: measurement using a MEPS-HPLC-F method
  54. Fast analysis of amino acids in wine by capillary electrophoresis with laser-induced fluorescence detection
  55. Chiral analysis of amphetamines, methadone and metabolites in biological samples by electrodriven methods
  56. Determination of aloe emodin in Aloe vera extracts and commercial formulations by HPLC with tandem UV absorption and fluorescence detection
  57. Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
  58. Determination of topiramate in human plasma by capillary electrophoresis with indirect UV detection
  59. Metabolism of Benzodiazepine and Non-Benzodiazepine Anxiolytic-Hypnotic Drugs: an Analytical Point of View
  60. Analysis of cocaine and two metabolites in dried blood spots by liquid chromatography with fluorescence detection: A novel test for cocaine and alcohol intake
  61. Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma
  62. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements
  63. Simultaneous HPLC determination of 14 tricyclic antidepressants and metabolites in human plasma
  64. Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE
  65. Determination of duloxetine in human plasma by capillary electrophoresis with laser-induced fluorescence detection
  66. Enantioseparation of the antidepressant reboxetine
  67. Benzodiazepine Metabolism: An Analytical Perspective
  68. Quantitative analysis of cocaine in human hair by HPLC with fluorescence detection
  69. Separation and HPLC analysis of 15 benzodiazepines in human plasma
  70. New environmental sensitive system for colon-specific delivery of peptidic drugs
  71. Enantioselective analysis of amisulpride in pharmaceutical formulations by means of capillary electrophoresis
  72. Electrodriven methods for the enantioseparation of second-generation antidepressant drugs: An update
  73. Determination of vigabatrin in human plasma by means of CE with LIF detection
  74. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection
  75. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure
  76. Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection
  77. Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes
  78. Analysis of aromatic and terpenic constituents of pepper extracts by capillary electrochromatography
  79. Possible levomepromazine–clozapine interaction: Two case reports
  80. Sensitive and selective determination of glutathione in probiotic bacteria by capillary electrophoresis–laser induced fluorescence
  81. Determination of amphetamines in human urine by liquid chromatography with fluorimetric detection using a solid-phase extraction procedure
  82. Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedure
  83. Capillary electrophoretic analysis of the antibiotic vancomycin in innovative microparticles and in commercial formulations
  84. HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma
  85. Fluoxetine Metabolism and Pharmacological Interactions: The Role of Cytochrome P450
  86. Enantioseparation and quality control of biperiden in pharmaceutical formulations by capillary electrophoresis
  87. Determination of the antidepressant mirtazapine and its two main metabolites in human plasma by liquid chromatography with fluorescence detection
  88. Advances in the enantioseparation of second-generation antidepressant drugs by electrodriven methods
  89. Separation and analysis of glycyrrhizin, 18β-glycyrrhetic acid and 18α-glycyrrhetic acid in liquorice roots by means of capillary zone electrophoresis
  90. Separation and analysis of the major constituents of cloves by micellar electrokinetic chromatography
  91. Enantioselective determination of the novel antidepressant mirtazapine and its active demethylated metabolite in human plasma by means of capillary electrophoresis
  92. Rapid analysis of olanzapine and desmethylolanzapine in human plasma using high-performance liquid chromatography with coulometric detection
  93. Simultaneous liquid chromatographic analysis of catecholamines and 4-hydroxy-3-methoxyphenylethylene glycol in human plasma
  94. Atypical Antipsychotics: Pharmacokinetics, Therapeutic Drug Monitoring and Pharmacological Interactions
  95. Micelles Based on Polyvinyl Alcohol Substituted with Oleic Acid for Targeting of Lipophilic Drugs
  96. High-performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures
  97. Analysis of plasma catecholamines by liquid chromatography with amperometric detection using a novel SPE ion-exchange procedure
  98. Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis
  99. Quality control of commercial tablets containing the novel antipsychotic quetiapine
  100. Determination of melatonin in commercial preparations by micellar electrokinetic chromatography and spectrofluorimetry
  101. Liquid chromatographic analysis of the cis(Z)- and trans(E)-isomers of clopenthixol in human plasma using a novel solid phase extraction procedure
  102. Determination of recent antidepressant citalopram in human plasma by liquid chromatography—Fluorescence detection
  103. Determination of progesterone in commercial formulations and in non conventional micellar systems
  104. Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction
  105. HPLC analysis of the novel antipsychotic drug quetiapine in human plasma
  106. Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction
  107. Rapid methods for determination of fluoxetine in pharmaceutical formulations
  108. Determination of reboxetine, a recent antidepressant drug, in human plasma by means of two high-performance liquid chromatography methods
  109. Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients
  110. Rapid capillary electrophoretic method for the determination of clozapine and desmethylclozapine in human plasma
  111. A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure
  112. Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry
  113. A rapid LC method for the identification and determination of CNS drugs in pharmaceutical formulations
  114. DEVELOPMENT OF AN HPLC METHOD FOR THE TOXICOLOGICAL SCREENING OF CENTRAL NERVOUS SYSTEM DRUGS
  115. Spectrophotometric determination of silicate traces in hemodialysis solutions
  116. Analytical methods for the quality control of Prozac® capsules
  117. Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorescence detection
  118. Determination of clozapine in human plasma by solid-phase extraction and liquid chromatography with amperometric detection
  119. Comparison of analytical methods for quality control of pharmaceutical formulations containing glutathione